Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides.

Yoshino N, Takeshita R, Kawamura H, Murakami K, Sasaki Y, Sugiyama I, Sadzuka Y, Kagabu M, Sugiyama T, Muraki Y, Sato S.

Scand J Immunol. 2018 Jun 23:e12698. doi: 10.1111/sji.12698. [Epub ahead of print]

PMID:
29935085
2.

[The Collaboration between Clinical Therapy and Academic Study to Benefit Patients].

Sugiyama I, Kudo K, Sadzuka Y.

Yakugaku Zasshi. 2018;138(6):767-772. doi: 10.1248/yakushi.17-00184-4. Review. Japanese.

3.

The effects of vitamin B6 compounds on cell proliferation and melanogenesis in B16F10 melanoma cells.

Matsuo T, Fujiwara A, Nakamura K, Sadzuka Y.

Oncol Lett. 2018 Apr;15(4):5181-5184. doi: 10.3892/ol.2018.7947. Epub 2018 Feb 5.

4.

Dual-effect liposomes with increased antitumor effects against 67-kDa laminin receptor-overexpressing tumor cells.

Sugiyama I, Kaihatsu K, Soma Y, Kato N, Sadzuka Y.

Int J Pharm. 2018 Apr 25;541(1-2):206-213. doi: 10.1016/j.ijpharm.2018.02.041. Epub 2018 Feb 24.

PMID:
29486285
5.

Extracellular acidification by lactic acid suppresses glucose deprivation-induced cell death and autophagy in B16 melanoma cells.

Matsuo T, Sadzuka Y.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1357-1361. doi: 10.1016/j.bbrc.2018.02.022. Epub 2018 Feb 5.

PMID:
29421654
6.

Effect of Mixing Time and Storage Condition on Characterization of Heparinoid Admixtures with Corticosteroids.

Sugiyama I, Takahashi N, Sadzuka Y.

Yakugaku Zasshi. 2016;136(10):1391-1400. Japanese.

7.

Effect of Liposomes with Different Double Arms Polyethyleneglycol on Hepatic Metastasis Model Mice and Evaluation Using a Fluorescent Imaging Device.

Sugiyama I, Oikawa H, Masuda T, Sadzuka Y.

Curr Drug Deliv. 2017;14(5):668-675. doi: 10.2174/1567201813666160328113653.

PMID:
27017825
8.
9.
10.

Polyethyleneglycol: a classical but innovative material. Foreword.

Sadzuka Y.

Biol Pharm Bull. 2013;36(6):877. No abstract available.

11.

Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity.

Miyashita M, Sadzuka Y.

Food Chem Toxicol. 2013 Mar;53:174-9. doi: 10.1016/j.fct.2012.11.035. Epub 2012 Dec 7.

PMID:
23220514
12.

Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin.

Sugiyama I, Sadzuka Y.

Int J Pharm. 2013 Jan 30;441(1-2):279-84. doi: 10.1016/j.ijpharm.2012.11.032. Epub 2012 Nov 27.

PMID:
23194885
13.

Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin.

Sadzuka Y, Nagamine M, Toyooka T, Ibuki Y, Sonobe T.

Int J Pharm. 2012 Aug 1;432(1-2):42-9. doi: 10.1016/j.ijpharm.2012.04.062. Epub 2012 Apr 28.

PMID:
22569233
14.

Beneficial effects by intake of Euphausiacea pacifica on high-fat diet-induced obesity.

Sadzuka Y, Sugiyama I, Miyashita M, Ueda T, Kikuchi S, Oshiro E, Yano A, Yamada H.

Biol Pharm Bull. 2012;35(4):568-72.

15.
16.

[Preparation of liposome using egg yolk].

Sugiyama I, Sadzuka Y.

Yakugaku Zasshi. 2011;131(10):1519-25. Japanese.

17.

[Utility and improvement of liposome injections AmBisome for clinical use].

Sugiyama I, Kudo K, Takahashi K, Sadzuka Y.

Yakugaku Zasshi. 2010 Mar;130(3):457-61. Japanese.

18.

Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment.

Sadzuka Y, Hatakeyama H, Sonobe T.

Int J Pharm. 2010 Jan 4;383(1-2):186-91. doi: 10.1016/j.ijpharm.2009.08.040. Epub 2009 Sep 2.

PMID:
19732815
19.

The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin.

Sadzuka Y, Matsuura M, Sonobe T.

Biol Pharm Bull. 2009 Sep;32(9):1584-7.

20.

Effect of hybridized liposome by novel modification with some polyethyleneglycol-lipids.

Sugiyama I, Sonobe T, Sadzuka Y.

Int J Pharm. 2009 May 8;372(1-2):177-83. doi: 10.1016/j.ijpharm.2009.01.010. Epub 2009 Jan 20.

PMID:
19429278
21.

Effects of a single-dose administration of Bowman-Birk inhibitor concentrate on anti-proliferation and inhabitation of metastasis in M5076 ovarian sarcoma-bearing mice.

Sakurai N, Suzuki K, Sano Y, Saito T, Yoshimura H, Nishimura Y, Yano T, Sadzuka Y, Asano R.

Mol Med Rep. 2008 Nov-Dec;1(6):903-7. doi: 10.3892/mmr_00000048.

PMID:
21479504
22.

Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization.

Sadzuka Y, Iwasaki F, Sugiyama I, Horiuchi K, Hirano T, Ozawa H, Kanayama N, Oku N.

Toxicol Lett. 2008 Nov 10;182(1-3):110-4. doi: 10.1016/j.toxlet.2008.09.002. Epub 2008 Sep 12.

PMID:
18835340
23.

Connexin 43-dependent tumor-suppressing effect of the Bowman-Birk protease inhibitor on M5076 ovarian sarcoma-bearing mice.

Sakurai N, Suzuki K, Nagaoka T, Saito T, Yoshimura H, Yano T, Sadzuka Y, Asano R.

Mol Med Rep. 2008 Sep-Oct;1(5):689-93. doi: 10.3892/mmr_00000014.

PMID:
21479471
24.

Novel method for stratum corneum pore size determination using positron annihilation lifetime spectroscopy.

Itoh Y, Shimazu A, Sadzuka Y, Sonobe T, Itai S.

Int J Pharm. 2008 Jun 24;358(1-2):91-5. doi: 10.1016/j.ijpharm.2008.02.016. Epub 2008 Mar 10.

PMID:
18434047
25.

A liposomal formulation study of 2,7-dichlorodihydrofluorescein for detection of reactive oxygen species.

Sadzuka Y, Nakagawa K, Yoshioka H, Sonobe T.

Int J Pharm. 2008 May 22;356(1-2):300-5. doi: 10.1016/j.ijpharm.2008.01.019. Epub 2008 Jan 19.

PMID:
18294791
26.

Influence of load on particle size distribution of lactose-crystalline cellulose mixed powder.

Nakamori T, Miyagishim A, Nozawa Y, Sadzuka Y, Sonobe T.

Int J Pharm. 2008 Apr 16;354(1-2):255-9. doi: 10.1016/j.ijpharm.2007.11.043. Epub 2007 Nov 29.

PMID:
18258396
27.

Screening of biochemical modulator by tumor cell permeability of doxorubicin.

Sadzuka Y, Hatakeyama H, Daimon T, Sonobe T.

Int J Pharm. 2008 Apr 16;354(1-2):63-9. Epub 2007 Oct 22.

PMID:
18054183
28.

Study on liposomalization of zinc-coproporphyrin I as a novel drug in photodynamic therapy.

Sadzuka Y, Iwasaki F, Sugiyama I, Horiuchi K, Hirano T, Ozawa H, Kanayama N, Sonobe T.

Int J Pharm. 2007 Jun 29;338(1-2):306-9. Epub 2007 Feb 9.

PMID:
17349754
29.

Anserine induced advantage effects on the antitumor activity of doxorubicin.

Sadzuka Y, Sonobe T.

Food Chem Toxicol. 2007 Jun;45(6):985-9. Epub 2006 Dec 13.

PMID:
17240507
30.

Characterization of novel mixed polyethyleneglycol modified liposomes.

Sugiyama I, Sadzuka Y.

Biol Pharm Bull. 2007 Jan;30(1):208-11.

31.

Physical characteristics of freeze-dried griseofulvin-lipids nanoparticles.

Kamiya S, Nozawa Y, Miyagishima A, Kurita T, Sadzuka Y, Sonobe T.

Chem Pharm Bull (Tokyo). 2006 Feb;54(2):181-4.

32.

Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.

Sadzuka Y, Sugiyama I, Tsuruda T, Sonobe T.

Int J Pharm. 2006 Apr 7;312(1-2):83-9. Epub 2006 Feb 2.

PMID:
16457972
33.

The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.

Sadzuka Y, Tokutomi K, Iwasaki F, Sugiyama I, Hirano T, Konno H, Oku N, Sonobe T.

Cancer Lett. 2006 Sep 8;241(1):42-8. Epub 2005 Nov 21.

PMID:
16303246
34.

Liposomalization of SN-38 as active metabolite of CPT-11.

Sadzuka Y, Takabe H, Sonobe T.

J Control Release. 2005 Nov 28;108(2-3):453-9. Epub 2005 Sep 22.

PMID:
16182400
35.

Effects of theanine on alcohol metabolism and hepatic toxicity.

Sadzuka Y, Inoue C, Hirooka S, Sugiyama T, Umegaki K, Sonobe T.

Biol Pharm Bull. 2005 Sep;28(9):1702-6.

36.

Efficacy of theanine is connected with theanine metabolism by any enzyme, not only drug metabolizing enzymes.

Sadzuka Y, Sugiyama T, Nagamine M, Umegaki K, Sonobe T.

Food Chem Toxicol. 2006 Feb;44(2):286-92. Epub 2005 Sep 6.

PMID:
16140449
37.

Applicability of anti-neovascular therapy to drug-resistant tumor: suppression of drug-resistant P388 tumor growth with neovessel-targeted liposomal adriamycin.

Shimizu K, Asai T, Fuse C, Sadzuka Y, Sonobe T, Ogino K, Taki T, Tanaka T, Oku N.

Int J Pharm. 2005 May 30;296(1-2):133-41. Epub 2005 Apr 11.

PMID:
15885465
38.

Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.

Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R.

Oncol Rep. 2005 Jun;13(6):1247-50.

PMID:
15870950
39.

Glycerin fatty acid esters as a new lubricant of tablets.

Aoshima H, Miyagisnima A, Nozawa Y, Sadzuka Y, Sonobe T.

Int J Pharm. 2005 Apr 11;293(1-2):25-34.

PMID:
15778041
40.

[Characterization and cytotoxicity of mixed PEG-DSG modified liposomes].

Sadzuka Y, Tsuruda T, Sonobe T.

Yakugaku Zasshi. 2005 Jan;125(1):149-57. Japanese.

41.

Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.

Maeda N, Takeuchi Y, Takada M, Sadzuka Y, Namba Y, Oku N.

J Control Release. 2004 Nov 5;100(1):41-52.

PMID:
15491809
43.

Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.

Sadzuka Y, Sugiyama T, Suzuki H, Sawanishi H, Miyamoto K.

Toxicol Lett. 2004 May 2;150(3):341-9.

PMID:
15110086
44.

A dosage design of mitomycin C tablets containing finely powdered green tea.

Kurita T, Miyagishima A, Nozawa Y, Sadzuka Y, Sonobe T.

Int J Pharm. 2004 May 4;275(1-2):279-83.

PMID:
15081158
45.

Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.

Ishida T, Ichikawa T, Ichihara M, Sadzuka Y, Kiwada H.

J Control Release. 2004 Mar 24;95(3):403-12.

PMID:
15023452
46.

Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.

Sugiyama T, Sadzuka Y.

Biochim Biophys Acta. 2003 Dec 5;1653(2):47-59. Review.

PMID:
14643924
47.

Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase.

Kondo M, Asai T, Katanasaka Y, Sadzuka Y, Tsukada H, Ogino K, Taki T, Baba K, Oku N.

Int J Cancer. 2004 Jan 10;108(2):301-6.

48.

Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.

Igarashi A, Konno H, Tanaka T, Nakamura S, Sadzuka Y, Hirano T, Fujise Y.

Toxicol Lett. 2003 Nov 30;145(2):133-41.

PMID:
14581165
49.

Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin.

Sadzuka Y, Nakade A, Tsuruda T, Sonobe T.

J Control Release. 2003 Sep 4;91(3):271-80.

PMID:
12932707
50.

Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes.

Sadzuka Y, Kishi K, Hirota S, Sonobe T.

J Liposome Res. 2003 May;13(2):157-72.

PMID:
12855110

Supplemental Content

Loading ...
Support Center